Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...

As cancer lawsuits cut into profits, Roundup-producer Bayer is behind legislation in 12 states and Congress to shield ...

The latest Market Talks covering Basic Materials. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

Bayer (BAYRY) stock gains as the company raises 2025 financial outlook, citing strong pharma performance. Read more here.

German pharmaceutical and agricultural chemicals giant Bayer said it had put aside an extra 1.2 billion euros ($1.4 billion) ...

PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...